Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 7Hot Flashes 4Depression 2Pain, Postoperative 1Pain 1Lung Neoplasms 1Anxiety Disorders 1Acute Pain 1

Interventions

Psychiatric Rehabilitation 13Therapeutics 7Early Intervention, Educational 5Yoga 4Surveys and Questionnaires 4Methods 4Saline Solution 3Mindfulness-Based Cognitive Therapy 3Mindfulness 3Esketamine 3Chemotherapy, Adjuvant 3Transcranial Direct Current Stimulation 2Melatonin 2Gabapentin 2Exercise Therapy 2Exercise 2Educational Status 2Counseling 2Control Groups 2Cognitive Behavioral Therapy 2Acupuncture Therapy 2abacavir 1Water 1Venlafaxine Hydrochloride 1Vegetables 1Typhoid-Paratyphoid Vaccines 1Therapeutic Touch 1Tamoxifen 1Stress Mindset Measure 1Sertraline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Depression × Gabapentin × Breast × Clear all
NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

NCT00022074 2015-10-15

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

University of Rochester

Phase NA Completed
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡